Tackling COVID-19 Using Remdesivir and Favipiravir as Therapeutic Options #MMPMID33031623
Sreekanth Reddy O; Lai WF
Chembiochem 2021[Mar]; 22 (6): 939-948 PMID33031623show ga
The human world is currently influenced largely by the outbreak of pandemic COVID-19. At this moment, most researchers focus on developing treatment strategies and measures to work against COVID-19. Treatment strategies specific for COVID-19 are lacking. This article provides an overview of the life cycle and routes of transmission of SARS-CoV-2. The therapeutic effects of two drugs [i. e., remdesivir (RDV) and favipiravir (FPV)] which can potentially tackle COVID-19 are discussed based on current published data. This review can serve as a reference for future studies.